Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Sabrina Bortoluzzi"'
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
The CD1d-restricted Vα14 invariant NKT (iNKT) cell lineage in mice (Vα24 in humans) represents an evolutionary conserved innate-like immune cell type that recognizes glycolipid antigens. Because of their unique ability to promptly secrete copious a
Externí odkaz:
https://doaj.org/article/5479c5e5bb8b4f7794d4082820e745c7
Autor:
Thorsten Buch, Nyambayar Dashtsoodol, Tim Ammon, Sabine Helmrath, Roland Rad, Marc Schmidt-Supprian, Christoph Drees, Rupert Öllinger, Thomas Engleitner, Maria Solovey, Masahiro Ono, Michael Flossdorf, Sabrina Bortoluzzi, Jonas Mir, Maria Colomé-Tatché, Albulena Toska, Bahire Kalfaoglu
Publikováno v:
Immunity 54, 2497-2513.e9 (2021)
Summary Innate-like T cell populations expressing conserved TCRs play critical roles in immunity through diverse developmentally acquired effector functions. Focusing on the prototypical lineage of invariant natural killer T (iNKT) cells, we sought t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c06da347861c4bc75a26d906b2dbb053
https://pubmed.ncbi.nlm.nih.gov/34562377
https://pubmed.ncbi.nlm.nih.gov/34562377
Autor:
Christian Peschel, Christoph Drees, F. Thomas Wunderlich, Sabrina Bortoluzzi, Marc Schmidt-Supprian, Julius C. Fischer, Klaus Heger, J. Christoph Vahl
Publikováno v:
The Journal of Immunology. 198:2747-2759
NKT cells represent a small subset of glycolipid-recognizing T cells that are heavily implicated in human allergic, autoimmune, and malignant diseases. In the thymus, precursor cells recognize self-glycolipids by virtue of their semi-invariant TCR, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::948503dcdcda9a3a80e946de48282346
https://doi.org/10.4049/jimmunol.1601732
https://doi.org/10.4049/jimmunol.1601732
Autor:
Alessandro Coppe, Andrea Binatti, Noriko Senoo, Thomas P. Loughran, Hitoshi Sakai, Hideyuki Nakazawa, Nodoka Sekiguchi, Pekka Ellonen, Noriyasu Fukushima, Sonja Lagström, Satu Mustjoki, Fumihiro Ishida, Sayaka Nishina, Takeki Mitsui, Emma I. Andersson, Sabrina Bortoluzzi, Samuli Eldfors, Stefania Bortoluzzi, Yok-Lam Kwong, Kazuyuki Matsuda, Toru Kawakami, Jaroslaw P. Maciejewski, Takahiro Tanahashi, Vanessa Rebecca Gasparini
Publikováno v:
Blood
To the editor: Large granular lymphocyte (LGL) leukemia is a group of chronic lymphoproliferative disorders of cytotoxic T or natural killer (NK) cells frequently complicated with cytopenia and autoimmune phenomena.[1][1],[2][2] In the current World
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a6203aa9e4cbf4d01d2a17eae1bbe56
Autor:
Alessandro Coppe, Andersson, Emma I., Andrea Binatti, Gasparini, Vanessa R., Sabrina Bortoluzzi, Clemente, Michael J., Marco Herling, Maciejewski, Jaroslaw P., Satu Mustjoki, Stefania Bortoluzzi
Publikováno v:
University of Helsinki
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::f300317296fe9cce73d99ea731c1e6db
http://hdl.handle.net/11577/3236238
http://hdl.handle.net/11577/3236238
Autor:
Satu Mustjoki, Sonja Lagström, Thomas P. Loughran, Hanna Rajala, Sabrina Bortoluzzi, Alun Parsons, Samuli Eldfors, Jaroslaw P. Maciejewski, Pekka Ellonen, A. Laasonen, A. van Adrichem, Heikki Kuusanmäki, Thomas Olson, Caroline A. Heckman, Michael J. Clemente, Emma I. Andersson
Large granular lymphocyte (LGL) leukemia is a rare clonal disease characterized by a persistent increase in the number of CD8+ cytotoxic T cells or CD16/56+ natural killer (NK) cells.1 Patients are prone to recurrent infections and often suffer from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8e664baf80e00279ad2df694096b94f
https://europepmc.org/articles/PMC4814354/
https://europepmc.org/articles/PMC4814354/
Autor:
Andrea Binatti, Jaroslaw P. Maciejewski, Alessandro Coppe, Vanessa Rebecca Gasparini, Satu Mustjoki, Michael J. Clemente, Marco Herling, Sabrina Bortoluzzi, Stefania Bortoluzzi, Emma I. Andersson
Publikováno v:
Blood. 128:4117-4117
Background: Large granular lymphocyte (LGL) leukemia is a rare disease characterized by a clonal persistence of cytotoxic T cells or natural killer (NK) cells. Patients usually suffer from cytopenias and other organ-related autoimmune phenomena. Thes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::421223fe7829f9055a8ffc6b91779d7f
https://doi.org/10.1182/blood.v128.22.4117.4117
https://doi.org/10.1182/blood.v128.22.4117.4117